Fresenius Medcl Care
2 products tracked · names used in filings: Fresenius Medcl Care
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Mon 19 Oct 2026🇺🇸 FDA approval
FDA approves Calrezdy (calcuim chloride): new active ingredient
Fresenius Medcl Care; NDA219456; New active ingredient; solution · source
Mon 19 Oct 2026🇺🇸 FDA approval
FDA approves Cienby (sodium ctirate): new active ingredient
Fresenius Medcl Care; NDA219455; New active ingredient; solution · source
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇺🇸 | Calrezdy calcuim chloride | Approved | 2026-10-19 |
| 🇺🇸 | Cienby sodium ctirate | Approved | 2026-10-19 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.